If she's seeking a non-invasive, non-daily contraceptive option, think about discussing XULANE. XULANE is indicated for the prevention of pregnancy in women with a body mass index (BMI) <30 kg/m2 for whom a combined hormonal contraceptive is appropriate. Please see additional information about XULANE Limitations of Use below. Contraceptive counseling that includes discussing all of a patient’s options may reduce the risk of unintended pregnancy and helps facilitate correct and effective contraceptive use.1
Age 30, 5’5, 130lb;
BMI: 21.6kg/m2
Healthy, non-smoker
Lifestyle: College graduate and working professional. Travels for work a few times a month.
What she’s looking for in a birth control:
A birth control that has good insurance coverage, small and offers discrete placement under loose fitting clothes.
Age 19, 5’7, 168lb;
BMI: 26.3kg/m2
Healthy, non-smoker
Lifestyle: College student, very busy lifestyle, plays sports and enjoys going out with friends a few times a week.
What she’s looking for in a birth control:
Highly effective, non-daily option, no longer wants to take her daily birth control and wants to explore other options.
Age 27, 5’1, 135lb;
BMI: 25.5kg/m2
Healthy, non-smoker
Lifestyle: Recently married, working professional with a one year old child.
What she’s looking for in a birth control:
Non-invasive, reversible option that is highly effective and designed to fit her busy lifestyle.
XULANE may be less effective in preventing pregnancy in women who weigh 198 lbs (90 kg) or more. XULANE is contraindicated for use in women with BMI 30 kg/m2.
This is not the full list of Contraindications for XULANE. Please see additional information below.
XULANE does not protect against HIV infections (AIDS) and other sexually transmitted infections.
XULANE uses a 28-day (4-week) cycle. A new patch is applied on the same day each week for 3 weeks (21 total days). Week 4 is patch-free. Withdrawal bleeding expected during this time. She should check her patch every day to make sure all edges are sticking securely to the skin for it to work properly.
There may be an increased risk of VTE among women who use the XULANE patch compared to women who use certain COCs.
The AUC for EE is approximately 60% higher in women using XULANE compared to COCs containing EE 35 mcg. In contrast, the peak concentration (Cmax) for EE is approximately 25% lower in women using NGMN/EE transdermal system.
Discuss your patient's individual medical history and lifestyle, the safety and efficacy of the drug, dosing frequency and the dosage form to determine if XULANE patch is appropriate for her.
National Coverage & Copay Stats*
-XULANE Patch – 95% of patients are covered nationally across all plans†2
95% of insured lives Do NOT have any plan restrictions to access the XULANE patch†2
-Nationally, nearly 91% of all filled XULANE prescriptions for patients with commercial insurance had a $0 patient out-of-pocket costs after insurance for the 12 months ending 11/30/213
*It is the sole responsibility of the treating healthcare professional to confirm coverage, coding, and claim submission guidance with the patient’s health insurance plan to ensure XULANE claims are accurate, complete, and supported by documentation in the patient’s medical record. Allowable ICD-10 codes may vary by payer. Viatris does not guarantee that payers will consider all codes appropriate for all encounter scenarios and Viatris does not guarantee XULANE coverage or reimbursement.
†Commercial, managed Medicaid, and state Medicaid.
XULANE is indicated for the prevention of pregnancy in women with a body mass index (BMI) < 30 kg/m2 for whom a combined hormonal contraceptive is appropriate.
XULANE may be less effective in preventing pregnancy in women who weigh 198 lbs. (90 kg) or more. XULANE is contraindicated for use in women with BMI ≥ 30 kg/m2 [see Contraindications (4), Warnings and Precautions (5.1) and Clinical Studies (14)].
WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS and CONTRAINDICATED IN WOMEN WITH A BMI ≥ 30 kg/m2
Patients should be counseled that XULANE does not protect against HIV infection (AIDS) and other sexually transmitted infections.
This is not all of the information you should read prior to prescribing XULANE. Click here for Full Prescribing Information, including Boxed WARNING.
WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS and CONTRAINDICATED IN WOMEN WITH A BMI ≥ 30kg/m2